Cargando…

Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach

Individuals exposed to spores of B. anthracis must take a course of antibiotics as postexposure prophylaxis (PEP) to prevent inhalation anthrax. During an anthrax event, public health authorities are responsible for conducting dispensing operations to offer PEP to exposed individuals. Jurisdictions...

Descripción completa

Detalles Bibliográficos
Autores principales: Misener, Mark, Starr, David T., Scaccia, Allison J., Arya, Vibhuti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340788/
https://www.ncbi.nlm.nih.gov/pubmed/30133374
http://dx.doi.org/10.1089/hs.2018.0025
_version_ 1783388830051598336
author Misener, Mark
Starr, David T.
Scaccia, Allison J.
Arya, Vibhuti
author_facet Misener, Mark
Starr, David T.
Scaccia, Allison J.
Arya, Vibhuti
author_sort Misener, Mark
collection PubMed
description Individuals exposed to spores of B. anthracis must take a course of antibiotics as postexposure prophylaxis (PEP) to prevent inhalation anthrax. During an anthrax event, public health authorities are responsible for conducting dispensing operations to offer PEP to exposed individuals. Jurisdictions have developed antibiotic PEP screening algorithms to determine which antibiotic is appropriate for each individual. Variability exists with regard to screening questions and dispensing decisions based on responses to those questions. It is likely that individuals with similar profiles will receive different antibiotics based solely on the jurisdiction in which they receive their PEP. This lack of consistency among jurisdictions may lead to a loss of confidence in the public health response among the public, the healthcare community, the media, and government leaders, which could compromise the response itself. We present New York City's planning assumptions, screening algorithm, a rationale for our screening questions, and our reasons for excluding screening questions asked by other jurisdictions. We hope that our efforts may assist others in developing and refining their algorithms and associated public messaging and encourage standardization with neighboring jurisdictions where appropriate.
format Online
Article
Text
id pubmed-6340788
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-63407882019-01-22 Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach Misener, Mark Starr, David T. Scaccia, Allison J. Arya, Vibhuti Health Secur Original Articles Individuals exposed to spores of B. anthracis must take a course of antibiotics as postexposure prophylaxis (PEP) to prevent inhalation anthrax. During an anthrax event, public health authorities are responsible for conducting dispensing operations to offer PEP to exposed individuals. Jurisdictions have developed antibiotic PEP screening algorithms to determine which antibiotic is appropriate for each individual. Variability exists with regard to screening questions and dispensing decisions based on responses to those questions. It is likely that individuals with similar profiles will receive different antibiotics based solely on the jurisdiction in which they receive their PEP. This lack of consistency among jurisdictions may lead to a loss of confidence in the public health response among the public, the healthcare community, the media, and government leaders, which could compromise the response itself. We present New York City's planning assumptions, screening algorithm, a rationale for our screening questions, and our reasons for excluding screening questions asked by other jurisdictions. We hope that our efforts may assist others in developing and refining their algorithms and associated public messaging and encourage standardization with neighboring jurisdictions where appropriate. Mary Ann Liebert, Inc., publishers 2018-08-01 2018-12-29 /pmc/articles/PMC6340788/ /pubmed/30133374 http://dx.doi.org/10.1089/hs.2018.0025 Text en © Mark Misener, et al., 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Articles
Misener, Mark
Starr, David T.
Scaccia, Allison J.
Arya, Vibhuti
Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach
title Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach
title_full Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach
title_fullStr Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach
title_full_unstemmed Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach
title_short Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach
title_sort screening for anthrax postexposure antibiotic prophylaxis—the new york city approach
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340788/
https://www.ncbi.nlm.nih.gov/pubmed/30133374
http://dx.doi.org/10.1089/hs.2018.0025
work_keys_str_mv AT misenermark screeningforanthraxpostexposureantibioticprophylaxisthenewyorkcityapproach
AT starrdavidt screeningforanthraxpostexposureantibioticprophylaxisthenewyorkcityapproach
AT scacciaallisonj screeningforanthraxpostexposureantibioticprophylaxisthenewyorkcityapproach
AT aryavibhuti screeningforanthraxpostexposureantibioticprophylaxisthenewyorkcityapproach